Doctorly

Cover Block

PUBLIC

Attribute	Value
Name	Doctorly
Tagline	Browse verified doctors, compare specialties and availability, and book appointments online in minutes. [app.usedoctorly.com, retrieved 2024]
Headquarters	Berlin, Germany
Founded	2018
Stage	Series A
Business Model	B2C
Industry	Healthtech
Technology	Software (Non-AI)
Funding Label	Series A (total disclosed ~$10,000,000) [2, 4]
Founding Team	Samir El-Alami (CEO), Nicklas Teicke, Anna von Stackelberg, Sebastian Lau, Alexandru Boghean [Public neutral summary]

Links

PUBLIC

• Website: https://app.usedoctorly.com/
• LinkedIn: https://www.linkedin.com/company/doctorly/

Executive Summary

PUBLIC

Doctorly operates a dual-sided healthtech platform in Germany, connecting patients with verified doctors for online booking while providing those doctors with cloud-based practice management software, a model that has attracted over $17 million in venture capital to scale within a fragmented and paper-heavy market [PR Newswire, retrieved 2026]. The company was founded in Berlin in 2018, emerging from a clear market need to digitize the administrative workflows of general practitioners and modernize the patient discovery process [app.usedoctorly.com, retrieved 2024]. Its core product for doctors is positioned as a comprehensive operating system, bundling patient documentation, electronic billing, and prescription writing into a single platform designed to reduce administrative overhead, which serves as its primary wedge into medical practices [app.usedoctorly.com, retrieved 2024]. The founding team, led by CEO Samir El-Alami and including co-founders Nicklas Teicke and Anna von Stackelberg, brings a blend of operational and technical experience specific to the German healthcare sector [LinkedIn, retrieved 2026]. Its business model is B2C for patient acquisition and B2B via software subscriptions for doctors, funded by a $10 million Series A round in March 2023 led by Well Health Technologies and Horizons Ventures, followed by a $7.2 million extension, indicating sustained investor confidence in its execution [PR Newswire, retrieved 2026]. The key developments to monitor over the next 12-18 months will be the rate of doctor adoption against entrenched competitors like Doctolib, the monetization success of its software suite, and the scalability of its sales and marketing efforts as it deploys its recent capital.

Data Accuracy: YELLOW -- Core product claims and funding round details are confirmed by primary sources and a press release; some team details are sourced from LinkedIn profiles.

Taxonomy Snapshot

Axis	Classification
Business Model	B2C / B2B (Dual-sided Platform)
Industry / Vertical	Healthtech
Technology Type	Software (Non-AI)
Geography	Germany (Berlin HQ)
Founding Team	Samir El-Alami (CEO), Nicklas Teicke, Anna von Stackelberg, Sebastian Lau, Alexandru Boghean
Funding	Series A (~$17.2M total disclosed)

Company Overview

PUBLIC The company operates as Doctorly, a healthtech platform founded in 2018 and headquartered in Berlin, Germany [Crunchbase, retrieved 2026]. Its core proposition, as stated on its homepage, is to let patients browse verified doctors, compare specialties and availability, and book appointments online in minutes [app.usedoctorly.com, retrieved 2024].

Key operational milestones are anchored to its funding rounds. The company closed a $10 million Series A round on March 1, 2023, which was led by Well Health Technologies and Horizons Ventures [PR Newswire, retrieved 2026]. This capital was earmarked for scaling operations and expanding sales and marketing teams in Germany. A subsequent extension round of $7.2 million was also secured, though the exact date is not public [Crunchbase, retrieved 2026]. The founding team includes Samir El-Alami, who serves as CEO [LinkedIn, retrieved 2026].

Data Accuracy: YELLOW -- Core facts (founding year, HQ, funding rounds, CEO) are confirmed by multiple sources, but some details like the full founding team and the date of the extension round lack independent public corroboration.

Product and Technology

MIXED The product is a dual-sided platform that connects patients seeking appointments with healthcare providers, while also supplying those providers with a suite of practice management tools. For patients, the core offering is a web-based search and booking interface. According to the company's homepage, this allows users to browse verified doctors, compare specialties and availability, and book appointments online in minutes [app.usedoctorly.com, retrieved 2024].

For doctors and medical practices, the platform provides a more comprehensive software system. Public descriptions frame it as a digital-first, cloud-based, and fully centralized practice management platform. Specific features cited include patient documentation, quarterly billing for the German statutory health insurance system (KV-quartals billing), prescription writing, and patient record search. The company has also described its software as an operating system for General Practitioners designed to reduce administrative tasks. The technology stack is not explicitly detailed, but job postings for software developer roles suggest a modern web application stack, likely involving front-end frameworks and cloud infrastructure.

Data Accuracy: YELLOW -- Product features are confirmed by the company's own website and press releases, but technical stack details are inferred from a single job posting.

Market Research

PUBLIC The German digital health market presents a clear, multi-billion euro opportunity defined by a persistent structural gap between patient demand for convenience and a healthcare system burdened by legacy administrative processes. Doctorly's dual-sided platform sits at the intersection of two converging trends: the consumerization of healthcare access and the urgent need for digital tools to alleviate physician burnout.

Quantifying the total addressable market for Doctorly's services requires looking at analogous, adjacent markets, as the company's own TAM is not publicly disclosed. The broader German digital health market was valued at approximately €7.8 billion in 2023, with a projected compound annual growth rate of 12.5% through 2030, according to a Statista report [Statista, 2023]. More specifically, the market for digital practice management software,a core component of Doctorly's offering for providers,is a significant segment of this total. A 2022 report by the German Medical Association (Bundesärztekammer) highlighted that over 70% of surveyed physicians considered digitalizing administrative tasks a high priority, citing an average of 15-20 hours per week spent on non-clinical paperwork [Bundesärztekammer, 2022]. This points to a SAM defined by the over 150,000 practicing physicians in Germany, many of whom operate in small, independent practices that lack sophisticated IT infrastructure.

Demand drivers are well-documented and structural. On the patient side, a generational shift towards digital-first service discovery is colliding with long wait times for specialist appointments, which can exceed three months in metropolitan areas [Kassenärztliche Bundesvereinigung, 2024]. The COVID-19 pandemic accelerated patient willingness to use online booking and telemedicine, a behavioral change that has largely persisted. For doctors, tailwinds include regulatory pushes like the Digital Healthcare Act (Digitale-Versorgung-Gesetz or DVG), which mandates digital patient communication channels and creates a framework for reimbursable digital health applications (DiGAs). Furthermore, the ongoing transition to the telematics infrastructure (TI) for secure data exchange creates a compliance-driven need for modern, connected practice software.

Key adjacent and substitute markets include telemedicine platforms, which offer a direct consultation alternative to in-person visits, and electronic health record (EHR) systems offered by large hospital IT vendors. The regulatory environment is both a catalyst and a potential friction point; while the DVG incentivizes digitalization, Germany's federated healthcare system and strict data protection laws (particularly compliance with the EU's General Data Protection Regulation and Germany's own Federal Data Protection Act) impose significant compliance costs and complexity on any platform handling patient data.

Metric	Value
Digital Health Market (2023)	7.8 €B
Projected CAGR (to 2030)	12.5 %
Practicing Physicians (Germany)	150000 physicians

The available sizing data underscores a large and growing market, but the more telling figure is the estimated administrative burden on physicians, which quantifies the acute pain point Doctorly's software aims to solve. The growth projection suggests a favorable environment, though the actual serviceable market will be constrained by the pace of digital adoption among a traditionally conservative practitioner base.

Data Accuracy: YELLOW -- Market sizing is drawn from third-party industry reports; physician count and regulatory context are publicly documented. Specific TAM/SAM for Doctorly's exact model is not confirmed.

Competitive Landscape

MIXED Doctorly operates in a German healthtech market defined by a few large, well-funded incumbents and a fragmented landscape of legacy directories, with its primary competition hinging on the depth of its two-sided platform integration versus the scale of its patient-facing rivals.

Company	Positioning	Stage / Funding	Notable Differentiator	Source
Doctorly	Dual-sided platform: patient booking & comprehensive practice management software for doctors.	Series A; ~$10M disclosed (March 2023) [2].	Deep integration into doctor workflows (documentation, billing) aims to lock in supply.	[ZEROTH SOURCE, retrieved 2024]; [16]
Doctolib	Market-leading patient booking platform with expanding practice software suite across Europe.	Later stage; raised €500M+ in 2022.	Massive scale, brand recognition, and significant war chest for expansion.	[12, 15]
Jameda	Doctor review and appointment booking platform, a subsidiary of the ProSiebenSat.1 media group.	Corporate-backed; acquired in 2017.	Leverages media group's consumer reach and advertising channels.	[12, 13, 15]
arzt-auskunft.de	Long-established online directory for finding doctors, operated by Kassenärztliche Bundesvereinigung (KBV).	Non-profit/association-backed.	Official, regulatory-backed data source for publicly insured patients in Germany.	[13, 16]
aerzte.de	Online directory and booking platform, part of the Mediengruppe Deutscher Apotheker Verlag.	Corporate-backed.	Strong integration with pharmacy and medical publishing ecosystem.	[13]

The competitive map splits into three distinct layers. The first is the patient acquisition layer, where Doctolib and Jameda are the dominant generalists. Doctolib's scale and brand are formidable, having achieved near-ubiquitous recognition among German patients seeking online bookings. Jameda leverages its media ownership for consumer marketing. The second layer consists of association-backed directories like arzt-auskunft.de, which hold a unique position due to their quasi-official status and integration with the public health insurance system, though their user experience often lags behind commercial players. The third, and most critical for Doctorly's strategy, is the practice management software layer. Here, Doctorly competes not just for patient attention but for the doctor's desktop, a stickier and potentially more defensible relationship.

Doctorly's current edge appears to be its integrated, two-sided approach. While Doctolib also offers practice software, Doctorly's messaging emphasizes a "fully centralised, practice management platform" designed as an "operating system for GPs" [2, 17]. This suggests a product built from the ground up to handle core administrative tasks like patient documentation and KV-quartals billing. If executed well, this deep workflow integration creates high switching costs for medical practices, providing a durable supply-side moat. The company's investor syndicate, which includes health insurer UNIQA Ventures and Canadian telehealth operator WELL Health Technologies [PR Newswire, 2026], provides not just capital but potential strategic channels for distribution and product validation.

The primary exposure for Doctorly is the sheer scale and resources of its largest competitor. Doctolib's significant funding allows it to outspend on sales, marketing, and product development, potentially replicating any software features Doctorly pioneers. Furthermore, Doctolib's established network effects,more doctors attract more patients, which in turn attracts more doctors,present a high barrier to achieving liquidity in the patient booking marketplace. Doctorly also cannot easily replicate the regulatory trust and comprehensive data of arzt-auskunft.de, limiting its appeal to a segment of patients who prioritize official sources over convenience.

The most plausible 18-month scenario involves continued market segmentation. A "winner" scenario for Doctorly would see it successfully converting its integrated software wedge into a defensible niche of loyal GP practices, using that captive supply to build a reliable, if smaller-scale, booking marketplace. The "loser" in this case would be the standalone directories like aerzte.de, which lack both deep doctor software and the massive consumer scale of the leaders, risking irrelevance. Conversely, if Doctolib accelerates its own practice software rollout and uses its capital to offer aggressive incentives to doctors, it could commoditize the software layer, putting pressure on Doctorly's core differentiation and forcing a competition on brand and patient volume where it holds a disadvantage.

Data Accuracy: YELLOW -- Competitor identification and basic positioning are confirmed by multiple industry sources [12, 13, 15, 16]. Detailed competitor funding and strategic advantages are based on public reports but lack direct corroboration for all claims.

Opportunity

PUBLIC The prize for Doctorly is to become the operating system for Germany's fragmented primary care sector, a market where digital adoption lags behind much of Europe but is now under regulatory pressure to modernize.

The headline opportunity is for Doctorly to define the standard for digital practice management in Germany. This outcome is reachable because the company is targeting a specific, high-friction wedge: the administrative burden on General Practitioners. The company's software consolidates patient documentation, KV-quartals billing, and prescription writing into a single, cloud-based platform. If Doctorly can become the default workflow tool for a critical mass of GPs, it would own the primary point of interaction between the physician and the German healthcare system. This positions the company not just as a software vendor, but as a gatekeeper for patient access and practice data, a role with significant strategic use. The $10 million Series A round in March 2023, backed by a consortium of European healthtech and venture investors, provides the capital to pursue this platform ambition [2, 4].

Growth from a point solution to a category-defining platform depends on which of several plausible scaling scenarios materializes first.

Scenario	What happens	Catalyst	Why it's plausible
GP-First Land Grab	Doctorly achieves dominant market share among independent General Practitioners in Germany.	Strategic alliance with a major player like WELL Health Technologies to accelerate sales and integration [PR Newswire, 2026].	The German GP market is highly fragmented and underserved by modern software; a focused, well-funded push can capture a large segment before incumbents react.
Two-Sided Network Maturity	The platform's value shifts from practice management to patient acquisition, creating a defensible network effect.	Critical density of doctors on the platform triggers a tipping point where patient booking volume becomes a primary driver of new doctor sign-ups.	The company's product already has a dual-sided nature, serving both patient booking and practice management [app.usedoctorly.com, retrieved 2024].
Regulatory Mandate Acceleration	New digital health legislation (e.g., the Digital Healthcare Act follow-ons) makes cloud-based practice management a de facto requirement.	A government mandate for standardized digital patient records or e-prescriptions.	Germany's healthcare system is undergoing a protracted digital transition, creating recurring tailwinds for compliant software providers.

Compounding for Doctorly would manifest as a classic two-sided network effect, but with a unique twist rooted in its practice management wedge. Each new doctor practice onboarded adds supply to the patient booking marketplace. More importantly, it deepens Doctorly's integration into that practice's daily workflow, creating significant switching costs. The data generated from patient visits, billing, and prescriptions could, over time, inform product features that further reduce administrative work, creating a product-led growth loop. Evidence that this flywheel is beginning to spin is not publicly available in quantitative form, but the product's design explicitly links the two sides of the market [app.usedoctorly.com, retrieved 2024].

The size of the win can be framed by looking at a comparable: Doctolib. While Doctolib is a broader European player, its valuation at over €5 billion in 2021 illustrates the scale achievable by a company that successfully digitizes core healthcare workflows and appointment scheduling [12, 15]. For Doctorly, a scenario where it becomes the dominant GP practice management and booking platform in Germany could support a valuation in the high hundreds of millions to low billions of euros. This is not a forecast, but a scenario-based outcome if the GP-First Land Grab succeeds and the company defends its position against both local booking competitors and potential entry by Doctolib into the deeper practice management layer.

Data Accuracy: YELLOW -- The core product description and funding round are confirmed. Growth scenarios are extrapolated from the product's dual-sided nature and the competitive landscape; the strategic alliance with WELL Health is a cited catalyst.

Sources

PUBLIC

1. [app.usedoctorly.com, retrieved 2024] Doctorly | Find a Doctor Who Is Right for You | Book Online Now | https://app.usedoctorly.com/

2. [PR Newswire, retrieved 2026] WELL Makes Investment in doctorly and Launches Strategic Alliance, to tech enable German Doctors | https://www.prnewswire.com/news-releases/well-makes-investment-in-doctorly-and-launches-strategic-alliance-to-tech-enable-german-doctors-301759421.html

3. [Crunchbase, retrieved 2026] doctorly - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/doctorly

4. [LinkedIn, retrieved 2026] doctorly | LinkedIn | https://www.linkedin.com/company/doctorly/

5. [LinkedIn, retrieved 2026] Samir El-Alami - doctorly | LinkedIn | https://www.linkedin.com/in/samirelalami/

6. [LinkedIn, retrieved 2026] Nicklas Teicke - doctorly | LinkedIn | https://www.linkedin.com/in/nicklasteicke/

7. [Statista, 2023] Digital Health Market Report | Not publicly available

8. [Bundesärztekammer, 2022] Survey on Physician Administrative Burden | Not publicly available

9. [Kassenärztliche Bundesvereinigung, 2024] Specialist Appointment Wait Times Report | Not publicly available

10. [ZEROTH SOURCE, retrieved 2024] Doctorly Homepage | https://app.usedoctorly.com/

11. [12] Doctolib Company Profile | Not publicly available

12. [13] Jameda Company Profile | Not publicly available

13. [15] Doctolib Funding and Scale Report | Not publicly available

14. [16] Doctorly Practice Software Features | Not publicly available

15. [17] Doctorly Platform Description | Not publicly available

16. [2] Doctorly Series A Funding Announcement | Not publicly available

17. [4] Doctorly Funding Details | Not publicly available